Free Trial
NASDAQ:ORGS

Orgenesis (ORGS) Stock Price, News & Analysis

$3.93
+0.10 (+2.61%)
(As of 10/8/2024 ET)

About Orgenesis Stock (NASDAQ:ORGS)

Key Stats

Today's Range
$3.76
$3.98
50-Day Range
N/A
52-Week Range
$2.50
$10.80
Volume
18,087 shs
Average Volume
18,987 shs
Market Capitalization
$135.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Orgenesis Inc., a biotech company, focuses on cell and gene therapies worldwide. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare network consisting of research institutes and hospitals. Its therapies include autologous; cell-based immunotherapies; and therapeutics for metabolic diseases, anti-viral diseases, and tissue regeneration. The company also provides development services, including regulatory services, pre-clinical studies, intellectual property services, and GMP process translation, as well as support services; hospital services; cell process development services; and distributed cell processing services. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is headquartered in Germantown, Maryland.

Orgenesis Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
42nd Percentile Overall Score

ORGS MarketRank™: 

Orgenesis scored higher than 42% of companies evaluated by MarketBeat, and ranked 690th out of 994 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Percentage of Shares Shorted

    1.10% of the outstanding shares of Orgenesis have been sold short.
  • Short Interest Ratio / Days to Cover

    Orgenesis has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Orgenesis has recently decreased by 6.84%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Orgenesis does not currently pay a dividend.

  • Dividend Growth

    Orgenesis does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.10% of the outstanding shares of Orgenesis have been sold short.
  • Short Interest Ratio / Days to Cover

    Orgenesis has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Orgenesis has recently decreased by 6.84%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Orgenesis this week, compared to 0 articles on an average week.
  • Search Interest

    2 people have searched for ORGS on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Orgenesis insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 5.66% of the stock of Orgenesis is held by insiders.

  • Percentage Held by Institutions

    Only 22.56% of the stock of Orgenesis is held by institutions.

  • Read more about Orgenesis' insider trading history.
Receive ORGS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orgenesis and its competitors with MarketBeat's FREE daily newsletter.

ORGS Stock News Headlines

45O.SG,0P0001J8IU,0 (45O.SG)
WARNING: “Buffett Indicator” flashing for first time in 50 years
The stock market collapsed and didn't recover for an entire decade. And what we're facing today could be even worse. That's why the actions you take in the next 90 days could be crucial for your financial future.
Why Orgenesis (ORGS) Stock Is Down 23% Today
Orgenesis Inc.: Orgenesis Announces Reverse Stock Split
Orgenesis Approves 1-for-10 Reverse Stock Split
Orgenesis Announces Reverse Stock Split
See More Headlines

ORGS Stock Analysis - Frequently Asked Questions

Orgenesis' stock was trading at $4.08 at the start of the year. Since then, ORGS stock has decreased by 3.7% and is now trading at $3.93.
View the best growth stocks for 2024 here
.

Orgenesis Inc. (NASDAQ:ORGS) announced its quarterly earnings data on Thursday, August, 8th. The company reported ($0.23) earnings per share (EPS) for the quarter. The business had revenue of $0.25 million for the quarter.

Orgenesis's stock reverse split before market open on Wednesday, September 25th 2024. The 1-10 reverse split was announced on Monday, September 23rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, September 24th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Orgenesis subsidiaries include these companies: Koligo Therapeutics, and Tamir Biotechnology Inc.

Shares of ORGS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Last Earnings
8/08/2024
Today
10/08/2024
Next Earnings (Estimated)
11/11/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ORGS
Fax
N/A
Employees
150
Year Founded
2008

Profitability

Net Income
$-55,360,000.00
Net Margins
-6,857.25%
Pretax Margin
-4,447.89%

Debt

Sales & Book Value

Annual Sales
$662,000.00
Book Value
($6.58) per share

Miscellaneous

Free Float
32,497,000
Market Cap
$133.65 million
Optionable
Optionable
Beta
1.21

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:ORGS) was last updated on 10/8/2024 by MarketBeat.com Staff
From Our Partners